QuidelOrtho

QuidelOrtho Corporation is a prominent in vitro diagnostics (IVD) provider formed from the merger of Quidel Corporation and Ortho Clinical Diagnostics. Headquartered in San Diego, California, the company ranks among the largest IVD providers globally, leveraging over 120 years of combined experience. With approximately 6,000 employees, QuidelOrtho generated over $3.5 billion in revenue in 2021. The company focuses on developing and manufacturing innovative diagnostic technologies that enhance testing performance and improve patient outcomes. QuidelOrtho offers a diverse range of diagnostic solutions, including rapid tests for infectious diseases, molecular diagnostics, immunoassay systems, and automated diagnostic systems. Their notable innovations include the first commercial pregnancy test and the first FDA-approved rapid antigen test for Influenza A and B. QuidelOrtho serves various segments of the healthcare continuum, from high-complexity hospitals to retail and over-the-counter markets.